{
    "2021-12-15": [
        [
            {
                "time": "",
                "original_text": "康泰生物(300601)：五价轮状病毒疫苗临床获批 研发管线再获完善",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "五价轮状病毒疫苗",
                        "临床获批",
                        "研发管线"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司获得腺病毒载体新冠疫苗在巴基斯坦、印度尼西亚商业化权利",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "腺病毒载体新冠疫苗",
                        "巴基斯坦",
                        "印度尼西亚",
                        "商业化权利"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗",
                        "国际合作"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司相关重组均已取得有权主管部门的批复，履行了法定程序",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "重组",
                        "主管部门批复",
                        "法定程序"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "企业合规"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司自主研发的13价肺炎球菌多糖结合疫苗2021年11月已在国内上市销售",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "13价肺炎球菌多糖结合疫苗",
                        "自主研发",
                        "国内上市销售"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗",
                        "自主研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司四联疫苗、23价肺炎球菌多糖疫苗、乙肝疫苗等取得了部分国家出口的证书",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联疫苗",
                        "23价肺炎球菌多糖疫苗",
                        "乙肝疫苗",
                        "出口证书"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗",
                        "国际市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：公司产品管线储备丰富，研发能力和生产规模位居国内疫苗行业前列",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "产品管线",
                        "研发能力",
                        "生产规模",
                        "疫苗行业前列"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗",
                        "研发能力"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}